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Abstract The plasminogen activator Pla of Yersinia pestis
belongs to the omptin family of enterobacterial surface proteases
and is responsible for the highly efficient invasion of the plague
bacterium from the subcutaneous infection site into the circulation.
Y. pestis has been reported to invade human epithelial cells. Here,
we investigated the role of Pla in bacterial invasion into human
endothelial cells. Expression of Pla in recombinant Escherichia
coli XL1(pMRK1) enhanced bacterial invasion into ECV304 cells.
The invasiveness was not affected by substitution mutation at the
residues S99 or D206 that are needed for the proteolytic activity of
Pla. Pla-expressing bacteria adhered to the extracellular matrix of
ECV304 cells. Only weak adhesion and poor invasion were seen
with the recombinant E. coli XL1(pMRK2), which expresses the
omptin homolog from E. coli. The results identify Pla as an
invasion protein of Y. pestis and show that the invasive function
does not involve the proteolytic activity of Pla. ß 2001 Feder-
ation of European Biochemical Societies. Published by Elsevier
Science B.V. All rights reserved.
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1. Introduction
Plague remains one of the most feared infectious diseases in
humans. The etiological agent of the disease, Yersinia pestis, is
disseminated by £eas and infects both humans and rodents.
Y. pestis is transmitted from rodents to humans by a £ea bite
and rapidly invades from the subcutaneous infection site into
the lymphatic system and circulation, to produce the systemic
and often fatal disease (reviewed in [1]). The bacterium is
highly invasive and has caused three pandemic waves of
plague with millions of deaths. Y. pestis still persists endemi-
cally in rodent populations in many countries and occasion-
ally causes local outbreaks. The plague epidemics are driven
by the dynamics of the disease in the rodent population [2,3].
Genetic analyses of Y. pestis populations have revealed that
the species is highly uniform and has evolved from the intes-
tinal pathogen Yersinia pseudotuberculosis serotype O1:b only
1500^20 000 years ago [4,5]. In view of the highly invasive
character of Y. pestis, it is surprising that Y. pestis lacks the
invasin and YadA proteins that promote invasion and viru-
lence of Y. pseudotuberculosis and Yersinia enterocolitica. The
inv gene of Y. pestis is inactivated through insertion of an
IS200-like element [6] and the yadA adhesin gene due to a
frameshift mutation [7]. On the other hand, Y. pestis has
two plasmids that are absent in other yersiniae: the 100-kb
plasmid pMT1 (also known as pFra) proposed to contribute
to the survival of the bacteria in the £ea [8], and the 9.5-kb
plasmid pPCP1 (also known as pPst), which is responsible for
the invasive character of plague in the mammalian host [9].
After subcutaneous administration of Y. pestis in mice,
pPCP1 potentiates the spread of bacteria into the circulation
[9]. It was recently demonstrated that pPCP1 also enhances
invasion of Y. pestis into human epithelial cells [10].
The plasmid pPCP1 encodes three proteins: pesticin, pesti-
cin immunity protein and the surface protein Pla. Of these,
Pla is required for the migration of Y. pestis from the sub-
cutaneous infection site into the circulation [11]. Pla appears
to be a multifunctional protein. It belongs to the omptin fam-
ily of enterobacterial surface proteins [12] and derives its name
from the fact that it can activate the mammalian plasma pro-
enzyme plasminogen into plasmin [13]. Bacterium-induced
formation of plasmin potentiates degradation of ¢brin [13]
and extracellular matrices [14] and promotes plague infection
in vivo [15]. Pla also cleaves the complement C3 component
[11], modi¢es bacterium-produced Yops (Yersinia outer pro-
teins) [16,17], and proteolytically inactivates K2-antiplasmin
[18]. K2-Antiplasmin is the major inhibitor of plasmin, and
its cleavage probably promotes uncontrolled proteolysis. In
addition to proteolytic functions, Pla has been found to me-
diate bacterial adhesion to eukaryotic cells and extracellular
matrices, especially to laminin [14,19].
Pla is an outer membrane protein, and we recently reported
a L-barrel topology model for the protein and identi¢ed pro-
teolytically important residues in it [18]. The predicted struc-
ture of Pla is highly similar to that of its homolog in Esche-
richia coli, OmpT. Pla and OmpT share 48% sequence identity
and have a similar L-barrel topology with 10 transmembrane
L-strands and ¢ve surface-exposed loops [18,20,21]. However,
they have di¡erences in their substrate speci¢city, as OmpT
activates plasminogen only weakly and does not cleave K2-
antiplasmin [18]. OmpT has been found to degrade denatured
bacterial proteins [22] and to cleave antimicrobial peptides in
the urine [23]. In this report, we show that expression of Pla
mediates invasion of recombinant E. coli into human endo-
thelial cells, whereas expression of OmpT confers no invasive-
ness. We also show that the invasion does not involve the
proteolytic activity of Pla.
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2. Materials and methods
2.1. Cell culture, bacterial strains, and plasmids
The spontaneously immortalized human umbilical vein endothelial
cell line ECV304 [24] was maintained in Medium 199 (Gibco Life
Technologies) supplemented with 10% fetal calf serum and 2 mM
L-glutamine. The cells were split twice weekly and, for invasion assays,
grown on 24-well plates (Nunc, Denmark) for 3 or 4 days. For adhe-
sion assays, the cells were grown on diagnostic slides (Diagnostica,
Germany) for 2 days (adhesion onto cells) or for 4 days (adhesion to
the extracellular matrix). The plasmids pMRK1 encoding Y. pestis
Pla, pMRK2 encoding E. coli OmpT and pMRK1(S99A) and
pMRK1(D206A) were expressed in E. coli XL1 and have been de-
scribed in detail [18]. Bacterial cultivation and induction of Pla and
OmpT with isopropyl L-D-thiogalactopyranoside (IPTG; Promega)
were performed as in [18], except that before invasion assays bacteria
were grown to the mid-exponential phase in the presence of 5 WM
IPTG.
2.2. Invasion assay
A standard gentamicin protection assay [25] was used to study bac-
terial invasion into ECV304 cells. Brie£y, ECV304 cells were washed
with phosphate-bu¡ered saline, pH 7.1 (PBS) and fresh Medium 199
was added. No fetal calf serum was added to the medium, since it has
been found to prevent Y. pestis invasion [10]. Bacteria (105 cfu) were
added and gently centrifuged (128Ug, 10 min) onto the cells to facil-
itate association between bacteria and the cells. Cells were incubated
for 2 h at 37‡C with 5% CO2, and after washing and killing of extra-
cellular bacteria with gentamicin (100 Wg/ml), the cells were lysed with
0.2% Triton X-100. The number of intracellular bacteria was deter-
mined by viable counting.
2.3. Adhesion assays
Bacteria (5U108/ml in Medium 199) were incubated on ECV304
cells for 2 h at 37‡C with 5% CO2. After washing six times with
PBS, the slides were ¢xed with methanol for 10 min, dried, and
stained with Giemsa stain. Bacterial adherence on the cells was exam-
ined with an Olympus BX50 microscope (Hamburg, Germany) and
the images were digitally recorded using the Image-Pro Plus program
(Media Cybernetics, Silver Spring, USA). To quantitate bacterial ad-
hesion to the extracellular matrix, the endothelial cells were detached
from the slides by detergent treatment [26] and adherence of the
bacteria (108/ml, 5U108/ml and 109/ml in PBS) on the remaining
matrix was de¢ned as described [14,27]. The number of bacteria in
20 randomly chosen microscopic ¢elds was determined.
3. Results
3.1. Y. pestis Pla mediates bacterial invasion into ECV304
human endothelial cells independently of its
proteolytic activity
Invasiveness of recombinant E. coli expressing Pla and
OmpT was studied by incubating bacteria on ECV304 cells.
Extracellular bacteria were killed with gentamicin, and the
number of intracellular bacteria was determined by viable
counting. E. coli XL1(pMRK1) expressing Pla invaded into
ECV304 cells (Fig. 1). The amount of bacteria released after
cell lysis was ca. 1% of the original bacterial inoculum in the
wells. The E. coli XL1 host strain carrying the vector plasmid
pSE380 alone did not invade ECV304 cells, indicating that
expression of Pla was required for invasion. In contrast to
Pla-expressing bacteria, invasion of E. coli XL1(pMRK2) ex-
pressing OmpT was negligible, only 0.005% of the bacteria
were internalized (Fig. 1). Bacterial growth in the assay wells
before gentamicin treatment was determined, and no signi¢-
cant di¡erences between the strains were noted. All assay
wells were done in triplicate and the assay was repeated
four times with essentially similar results ; a representative
example is shown in Fig. 1.
Substitution mutations S99A and D206A abolish the pro-
teolytic activity of Pla [18]. To ¢nd out whether the proteo-
lytic activity is required for invasion, we measured invasion of
recombinant bacteria carrying these substitutions. Invasion
rates of E. coli XL1(pMRK1)S99A and E. coli
XL1(pMRK1)D206A were close to those seen with the bac-
teria expressing wild-type Pla (Fig. 1). This suggests that the
proteolytic activity of Pla is not required for invasion. Also,
extragenously added plasminogen had no signi¢cant e¡ect on
the invasiveness of any of the strains (data not shown).
3.2. Adhesion of the bacteria to ECV304 cells and
extracellular matrix
Pla has earlier been found to mediate bacterial adhesion to
epithelial cells and extracellular matrices [14,19]. In this work,
we compared adhesion of Pla and OmpT to ECV304 endo-
thelial cells. E. coli XL1(pMRK1) expressing Pla adhered ef-
¢ciently to ECV304 cells. Adhesion was most prominent in
the intimate surroundings of the endothelial cells (Fig. 2A).
The proteolytically inactive mutants S99A and D206A medi-
ated as e⁄cient adhesion as the wild-type Pla (data not
shown). In contrast, E. coli XL1(pMRK2) expressing OmpT
adhered only weakly to ECV304 cells (Fig. 2A).
As the adherent bacteria seemed to localize mainly on the
surroundings of the cells, we measured bacterial adhesion to
the extracellular matrix secreted by the cells. The endothelial
cells were detached by detergent treatment, and the bacteria
were incubated on the remaining matrix. E⁄cient adhesion by
E. coli XL1(pMRK1), E. coli XL1(pMRK1)S99A and E. coli
XL1(pMRK1)D206A was noted (Fig. 2B). Adherence of
E. coli XL1(pMRK2) to the matrix was about four to ¢ve times
weaker than that of E. coli XL1(pMRK1), however, it showed
a weakly higher adherence than the E. coli XL1(pSE380) host
strain (Fig. 2B). None of the strains adhered to the control
surface coated with bovine serum albumin. These results indi-
cate that Pla is a more e⁄cient adhesin than OmpT.
4. Discussion
Migration through tissue barriers is a major task for a bac-
terial pathogen in its dissemination within the host body. The
Fig. 1. Invasion into ECV304 human endothelial cells of recombi-
nant E. coli XL1 expressing Pla (pMRK1), OmpT (pMRK2), or
mutated Pla devoid of proteolytic activity ((pMRK1)S99A and
(pMRK1)D206A). Invasion rate of the host strain E. coli
XL1(pSE380) is also shown. Invasion was measured as the percent-
age of inoculated bacteria surviving gentamicin treatment. Note the
e⁄cient invasion mediated by Pla and its derivatives, and the poor
invasion mediated by OmpT.
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process consists of two parts: (i) migration through extracel-
lular matrices beneath cells and (ii) passing through the cel-
lular layers themselves. Y. pestis is a remarkably invasive
bacterium, which during the plague infection migrates from
the subcutaneous infection site into the lymphatic and blood
vessels, and from there, into the liver and spleen. Other inter-
nal organs may also become colonized, and ultimately, bac-
teria colonize the lungs, which leads to the most contagious
phase of the disease with direct air-borne transmission to oth-
er susceptible mammals [1]. Such an e⁄cient dissemination
obviously involves bacterial migration through several epithe-
lial and endothelial layers.
Pathogenic bacteria can penetrate epithelial cell layers para-
cellularly (between the cells), transcellularly (by invading a
cell) or by facilitating transport inside a circulating phagocytic
cell, such as a monocyte [28]. Many pathogenic bacteria, in-
cluding Y. enterocolitica and Y. pseudotuberculosis, have been
demonstrated to invade eukaryotic cells in vitro [28,29]. Ear-
lier reports suggested that Y. pestis does not invade non-phag-
ocytic eukaryotic cells in vitro [30,31], however, it has been
found to survive and multiply inside professional phagocytes
[32,33]. The work by Cowan et al. [10] indicated that Y. pestis
invades HeLa human epithelioid cells in a highly e⁄cient
manner. Invasion is detected only in the absence of fetal
calf serum, which probably partly explains earlier ¢ndings
of non-invasiveness. Cowan et al. [10] found that the 9.5-kb
plasmid pPCP1 was the major bacterial factor contributing to
the invasion. Our results indicate that the Pla surface protein,
a product of pPCP1, promotes bacterial invasion into human
endothelial cells.
Pla-mediated invasion seems not to be dependent on the
proteolytic activity of Pla, as recombinant bacteria with the
protease-negative mutant proteins S99A and D206A were es-
sentially as invasive as bacteria expressing wild-type Pla. Ad-
dition of plasminogen and, thus, generation of plasmin had no
e¡ect on invasion, also suggesting that factors other than
proteolytic activity are involved in the observed invasiveness.
We have earlier shown that Pla is also an adhesin which
mediates bacterial binding to the extracellular matrix of
lung epithelial cells [14]. In this work, Pla was found to medi-
ate bacterial adhesion also to the matrix of ECV304 endothe-
lial cells. Interestingly, we found that OmpT-mediated adher-
ence to ECV304 cells and extracellular matrix is much weaker
than Pla-mediated adhesion. Furthermore, OmpT does not
promote bacterial invasion into ECV304 cells. The predicted
secondary structures of OmpT and Pla are very similar, how-
ever, the two omptins have profound di¡erences in their pro-
teolytic activities towards physiological targets [18]. This work
indicates that Pla and OmpT di¡er also in their ability to
adhere and invade into ECV304 cells. The di¡erences in the
reported functions between Pla and OmpT re£ect their viru-
lence roles. OmpT has been proposed to have a role in urinary
tract infections [34], but it is not associated with invasive in-
fections, whereas Pla is a well-established virulence factor of
the highly invasive Y. pestis. Several functions that are likely
to enhance migration of Y. pestis through the extracellular
matrix have been proposed for Pla [14,18]. Our present results
suggest that Pla is also involved in bacterial penetration
through the endothelial cells and may promote bacterial mi-
gration via a transcellular route.
It seems likely that there is a link between Pla-mediated
adhesion and invasion, but additional, yet unknown factors
in Pla may also a¡ect invasion. Adhesion to the extracellular
matrix has been proposed to have a role in invasion of Shi-
gella £exneri, since contact with extracellular matrix proteins
promotes the release of bacterial Ipa proteins that mediate
Shigella invasion [35]. The invasion rate of our Pla-expressing
recombinant E. coli is considerably lower than that observed
by Cowan et al. [10] for the pPCP1-positive Y. pestis ; invasion
of Y. pestis was extremely e⁄cient, after 1 h incubation 30^
50% of the bacteria were internalized into HeLa cells. The
di¡erence may result from poor growth of K-12 E. coli within
Fig. 2. A: Adhesion of Pla-expressing E. coli XL1(pMRK1),
OmpT-expressing E. coli XL1(pMRK2), and E. coli XL1(pSE380)
to ECV304 cells. Pla-expressing bacteria (arrow) adhere mainly onto
the intimate surroundings of the cells. OmpT-expressing bacteria
and the host strain with the vector plasmid adhere only weakly to
ECV304 cells. B: Adhesion to ECV304 cell matrix of Pla-expressing
E. coli XL1(pMRK1), OmpT-expressing E. coli XL1(pMRK2), as
well as E. coli XL1(pMRK1)S99A and E. coli XL1(pMRK1)D206A,
which express proteolytically inactive Pla. Pla-expressing bacteria
adhere e⁄ciently to the matrix, whereas adherence of OmpT-ex-
pressing bacteria is weak. None of the strains adheres to the control
surface coated with bovine serum albumin (BSA).
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the endothelial cells, and also may indicate that other factors
in Y. pestis, possibly in combination with Pla, also play a role
in invasion. Cowan et al. [10] estimated that 5^10% of the
invasiveness of Y. pestis was due to other factors than the
presence of pPCP1 plasmid. Although other, yet unidenti¢ed
factors may contribute to the invasiveness of Y. pestis, our
¢nding that Pla by itself renders a non-invasive E. coli K-12
strain invasive suggests that Pla has a signi¢cant role in the
invasion process.
In Y. pseudotuberculosis and Y. enterocolitica the surface
proteins invasin and YadA play central roles in adhesion
and invasion. Invasin promotes invasion by binding to L1-
integrins on the cell surface, and YadA binds to various cell
surface molecules and extracellular matrix components
[29,36]. Pla is known to bind to laminin on extracellular ma-
trices [14], but it is not yet known how the contact to host cell
surfaces is mediated in Y. pestis. Y. pestis evolved from
Y. pseudotuberculosis only shortly before the ¢rst plague pan-
demic [4]. Evolution has resulted in loss of the invasin and
YadA functions but, on the other hand, in gain of Pla, which
seems to have evolved to a remarkably multifunctional viru-
lence factor. Further work is required to solve the actual roles
of the various functions found in vitro for Pla. So far, plas-
minogen activation has been shown to be involved in Y. pestis
infection in vivo [15], but results from infection studies also
suggest that it is not the sole e¡ect mediated by Pla [11,15].
Current evidence suggests that Pla is a unique surface mole-
cule that provides the plague bacterium with a combination of
proteolytic, adhesive, and invasive functions.
Acknowledgements: This work was supported by the Academy of Fin-
land (project numbers 42103 and 45162) and by the University of
Helsinki. We thank Raili Lameranta for skilled technical assistance.
References
[1] Perry, R.D. and Fetherston, J.D. (1997) Clin. Microbiol. Rev. 10,
35^66.
[2] Shivaji, S., Bhanu, N.V. and Aggarwal, R.K. (2000) FEMS
Microbiol. Lett. 189, 247^252.
[3] Keeling, M.J. and Gilligan, C.A. (2000) Nature 407, 903^905.
[4] Achtman, M., Zurth, K., Morelli, G., Torrea, G., Guiyoule, A.
and Carniel, E. (1999) Proc. Natl. Acad. Sci. USA 96, 14043^
14048.
[5] Skurnik, M., Peippo, A. and Ervela«, E. (2000) Mol. Microbiol.
37, 316^330.
[6] Simonet, M., Riot, B., Fortineau, N. and Berche, P. (1996) In-
fect. Immun. 64, 375^379.
[7] Skurnik, M. and Wolf-Watz, H. (1989) Mol. Microbiol. 3, 517^
529.
[8] Hinnebusch, J., Cherepanov, P., Du, Y., Rudolph, A., Dixon,
J.D., Schwan, T. and Forsberg, Aî . (2000) Int. J. Med. Microbiol.
290, 483^487.
[9] Brubaker, R.R., Beesley, E.D. and Surgalla, M.J. (1965) Science
149, 422^424.
[10] Cowan, C., Jones, H.A., Kaya, Y.H., Perry, R.D. and Straley,
S.C. (2000) Infect. Immun. 68, 4523^4530.
[11] Sodeinde, O.A., Subrahmanyam, Y.V.B.K., Stark, K., Quan, T.,
Bao, Y. and Goguen, J.D. (1992) Science 258, 1004^1007.
[12] Mangel, W.F., Toledo, D.L., Brown, M.T., Worzalla, K.,
Lee, M. and Dunn, J.J. (1994) Methods Enzymol. 244, 384^
399.
[13] Beesley, E.D., Brubaker, R.R., Janssen, W.A. and Surgalla, M.J.
(1967) J. Bacteriol. 94, 19^26.
[14] La«hteenma«ki, K., Virkola, R., Sare¤n, A., Emo«dy, L. and Korho-
nen, T.K. (1998) Infect. Immun. 66, 5755^5762.
[15] Goguen, J.D., Bugge, T. and Degen, J.L. (2000) Methods 21,
179^183.
[16] Sample, A.K., Fowler, J.M. and Brubaker, R.R. (1987) Microb.
Pathogen. 2, 443^453.
[17] Sodeinde, O.A., Sample, A.K., Brubaker, R.R. and Goguen, J.D.
(1988) Infect. Immun. 56, 2749^2752.
[18] Kukkonen, M., La«hteenma«ki, K., Suomalainen, M., Kalkkinen,
N., Emo«dy, L., Lafing, H. and Korhonen, T.K. (2001) Mol.
Microbiol. 40, 1097^1111.
[19] Kienle, Z., Emo«dy, L., Svanborg, C. and O’Toole, P.W. (1992)
J. Gen. Microbiol. 138, 1679^1687.
[20] Kramer, R.A., Dekker, N. and Egmond, M.R. (2000) FEBS Lett.
468, 220^224.
[21] Kramer, R.A., Zandwijken, D., Egmond, M.R. and Dekker, N.
(2000) Eur. J. Biochem. 267, 885^893.
[22] White, C.B., Chen, Q., Kenyon, G.L. and Babbitt, P.C. (1995)
J. Biol. Chem. 270, 12990^12994.
[23] Stumpe, S., Schmid, R., Stephens, D.L., Georgiou, G. and Bak-
ker, E.P. (1998) J. Bacteriol. 180, 4002^4006.
[24] Takahashi, K., Sawasaki, Y., Hata, J.-I., Mukai, K. and Goto,
T. (1990) In Vitro Cell. Dev. Biol. 25, 265^274.
[25] Tang, P., Foubister, V., Pucciarelli, M.G. and Finlay, B.B. (1993)
J. Microbiol. Methods 18, 227^240.
[26] Hedman, K., Johansson, S., Vartio, T., Kjellen, L., Vaheri, A.
and Ho«o«k, M. (1982) Cell 28, 663^671.
[27] Toba, T., Virkola, R., Westerlund, B., Bjo«rkman, Y., Sillanpa«a«,
J., Vartio, T., Kalkkinen, N. and Korhonen, T.K. (1995) Appl.
Environ. Microbiol. 61, 2467^2471.
[28] Huang, S.-H. and Jong, A.Y. (2001) Cell. Microbiol. 3, 277^
287.
[29] Finlay, B.B. and Falkow, S. (1997) Microbiol. Mol. Biol. Rev.
61, 136^169.
[30] Sikkema, D.J. and Brubaker, R.R. (1987) Infect. Immun. 55,
572^578.
[31] Rosqvist, R., Forsberg, Aî ., Rimpila«inen, M., Bergman, T. and
Wolf-Watz, H. (1990) Mol. Microbiol. 4, 657^667.
[32] Cavanaugh, D.C. and Randall, R. (1959) J. Immunol. 83, 348^
363.
[33] Janssen, W.A. and Surgalla, M.J. (1969) Science 163, 950^
952.
[34] Webb, R.M. and Lundrigan, M.D. (1996) Med. Microbiol. Lett.
5, 8^14.
[35] Watarai, M., Tobe, T., Yoshikawa, M. and Sasakawa, C. (1995)
EMBO J. 14, 2461^2470.
[36] Cornelis, G.R., Boland, A., Boyd, A.P., Geuijen, C., Iriarte, M.,
Neyt, C., Sory, M.-P. and Stainier, I. (1998) Microbiol. Mol.
Biol. Rev. 62, 1315^1352.
FEBS 25181 17-8-01
K. La«hteenma«ki et al./FEBS Letters 504 (2001) 69^7272
